GlaxoSmithKline PLC - Publication of GSK 2019 Form 20-F
Annual Report 2019 on Form 20-F
In accordance with Section 203.01 of the New York Stock Exchange Listed Company Manual,
Ordinary Shareholders may also elect to receive notification by email of the publication of financial reports by registering on www.shareview.co.uk.
A hard copy version of the GSK 2019 Annual Report, together with the Notice of Annual General Meeting will be available on or about
Shareholders have the ability to receive, upon request, a hard copy version of GSK's complete audited financial statements for the year ended
(i) writing to
(ii) writing to
(iii) contacting the GSK Response Center in the
Cautionary statement regarding forward-looking statements
GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described under Item 3.D 'Risk factors" in the company's Annual Report on Form 20-F for 2019.
This information is provided by RNS, the news service of the
Quick facts: GlaxoSmithKline PLC
Market Cap: £83.98 billion
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE